Who We Are
about us
globeELIXIR Clinicals, a privately-owned well established full-service CRO (Contract Research Organization) and Specialized International Outsourcing Company, globeELIXIR is an efficient, metric- based Contact Research Organisation with a global footprint of operations Internationally, globeELIXIR Clinicals understand the importance of quality clinical research services and our significantly experienced team strives to provide the same to our sponsors at significant cost advantages. Representing a vertically integrated CRO, also we offer customised solutions to suit sponsor study requirements.
globeELIXIR Clinicals, offer trial management and monitoring, quality assurance, regulatory submissions, data management and biostatistics, etc., making the study assembly of a functional team ideally suited for clinical study. Our clients have ranged from big pharma to the emerging growth biotechnology sector. Our customized billing model helps us add new clients and retain our recurring clientele. globeELIXIR is offering clinical trial management service from small pilot studies to large multi-Center international clinical.
globeELIXIR Clinicals is responsible for planning, setup, and day-to-day execution and management of its contracted clinical trial. Handling and supervising the technical side data collection and medical testing, comprise a significant portion of its tasks. It is important to note that clinical compliance with regulatory agency guidelines is crucial, and adhering to Good Clinical Practice (GCP) standards is part of the CRO’s role as it acts as the trial’s central hub, connecting the sponsor with other stakeholders such as regulatory agencies, ethics committees, vendors, hospitals, etc.,
globeELIXIR also provides services to the pharmaceutical and biotechnology industries in the form of OUTSOURCED pharmaceutical, human research services (for both drugs and medical devices). globeELIXIR range from large, international full-service organizations to small, niche specialty groups and can offer their clients the experience of moving a new drug or device from its conception to regulatory marketing approval.